91 related articles for article (PubMed ID: 18450339)
1. Participation in two phase II prophylactic HIV vaccine trials in the UK.
Gray K; Legg K; Sharp A; Mackie N; Olarinde F; De Souza C; Weber J; Peters B
Vaccine; 2008 Jun; 26(23):2919-24. PubMed ID: 18450339
[TBL] [Abstract][Full Text] [Related]
2. A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa.
Jaspan HB; Soka NF; Mathews C; Flisher AJ; Mark D; Middelkoop K; Wood R; Bekker LG
Int J STD AIDS; 2010 Mar; 21(3):172-6. PubMed ID: 20215620
[TBL] [Abstract][Full Text] [Related]
3. Motivators to participation in medical trials: the application of social and personal categorization.
Dhalla S; Poole G
Psychol Health Med; 2013; 18(6):664-75. PubMed ID: 23360313
[TBL] [Abstract][Full Text] [Related]
4. Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial.
Sheon AR; Wagner L; McElrath MJ; Keefer MC; Zimmerman E; Israel H; Berger D; Fast P
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):519-26. PubMed ID: 9859967
[TBL] [Abstract][Full Text] [Related]
5. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
; Osmanov S
AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
[TBL] [Abstract][Full Text] [Related]
6. Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial.
Bakari M; Munseri P; Francis J; Aris E; Moshiro C; Siyame D; Janabi M; Ngatoluwa M; Aboud S; Lyamuya E; Sandström E; Mhalu F
BMC Public Health; 2013 Dec; 13():1149. PubMed ID: 24321091
[TBL] [Abstract][Full Text] [Related]
7. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand.
Thapinta D; Jenkins RA; Morgan PA; Chiu J; Boenim W; Bussaratid V; Chaddic C; Naksrisook S; Phonrat B; Sirijongdee N; Sornsathapornkul P; Sontirat A; Srisaengchai P; Suwanarach C; Wongkamhaeng S; Brown AE; Khamboonruang C; Nitayaphan S; Pitisuttithum P; Thongchareon P;
J Acquir Immune Defic Syndr; 2002 Aug; 30(5):503-13. PubMed ID: 12154341
[TBL] [Abstract][Full Text] [Related]
8. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
WHO/UNAIDS/IAVI International Expert Group
AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of a community sample about participation in future HIV vaccine trials in south India.
Nyamathi AM; Suhadev M; Swaminathan S; Fahey JL
AIDS Behav; 2007 Jul; 11(4):619-27. PubMed ID: 17016758
[TBL] [Abstract][Full Text] [Related]
10. Willingness to participate in South African HIV vaccine trials--concerns of medical professionals in the Western Cape.
Moodley K; Barnes J; van Rensburg EJ; Myer L
S Afr Med J; 2002 Nov; 92(11):904-6. PubMed ID: 12506594
[TBL] [Abstract][Full Text] [Related]
11. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
Dhalla S; Poole G
AIDS Care; 2011 Nov; 23(11):1430-47. PubMed ID: 21722022
[TBL] [Abstract][Full Text] [Related]
12. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
Allen M; Lau CY
Soc Sci Med; 2008 Feb; 66(4):945-51. PubMed ID: 18162272
[TBL] [Abstract][Full Text] [Related]
13. Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?
Newman PA; Duan N; Rudy ET; Anton PA
AIDS Patient Care STDS; 2004 Dec; 18(12):691-701. PubMed ID: 15659880
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials.
Maek-A-Nantawat W; Pitisuttithum P; Phonrat B; Bussaratid V; Naksrisook S; Peonim W; Thantamnu N; Muanaum R
J Med Assoc Thai; 2003 Apr; 86(4):299-307. PubMed ID: 12757073
[TBL] [Abstract][Full Text] [Related]
15. Statistical evaluation of HIV vaccines in early clinical trials.
Moodie Z; Rossini AJ; Hudgens MG; Gilbert PB; Self SG; Russell ND
Contemp Clin Trials; 2006 Apr; 27(2):147-60. PubMed ID: 16426900
[TBL] [Abstract][Full Text] [Related]
16. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
Brooks RA; Newman PA; Duan N; Ortiz DJ
AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
18. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G
AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079
[TBL] [Abstract][Full Text] [Related]
19. Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein.
Luzi AM; Gallo P; Colucci A; Marcotullio S; Bellino S; Longo O; Ensoli B
AIDS Care; 2011 Aug; 23(8):939-46. PubMed ID: 21390884
[TBL] [Abstract][Full Text] [Related]
20. Altruism motivates participation in a therapeutic HIV vaccine trial (CTN 173).
Balfour L; Corace K; Tasca GA; Tremblay C; Routy JP; Angel JB
AIDS Care; 2010 Nov; 22(11):1403-9. PubMed ID: 20936540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
